Michela Pasello
Overview
Explore the profile of Michela Pasello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
866
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pasello M, Laginestra M, Manara M, Landuzzi L, Ruzzi F, Maioli M, et al.
J Cell Commun Signal
. 2024 Nov;
18(3):e12047.
PMID: 39524141
Ewing sarcoma (EwS), a highly aggressive malignancy affecting children and young adults, is primarily driven by a distinctive oncogenic fusion, the EWSR1-ETS, whose activity is a key source of epigenetic...
2.
Casotti C, Hattinger C, Patrizio M, Luppi S, Fantoni L, Pasello M, et al.
Front Pharmacol
. 2023 Dec;
14:1294873.
PMID: 38074116
Methotrexate (MTX) is one of the most important drugs included in the first-line protocols to treat high-grade osteosarcoma (HGOS). Although several polymorphisms have been reported to be associated with drug...
3.
Manara M, Manferdini C, Cristalli C, Carrabotta M, Santi S, De Feo A, et al.
Cancer Immunol Res
. 2023 Dec;
12(2):247-260.
PMID: 38051221
Ewing sarcoma (EWS) is the second most common pediatric bone tumor. The EWS tumor microenvironment is largely recognized as immune-cold, with macrophages being the most abundant immune cells and their...
4.
Gartland A, Pasello M, Lezot F, Lamoureux F
Front Endocrinol (Lausanne)
. 2023 Feb;
14:1137736.
PMID: 36742406
No abstract available.
5.
Pasello M, Giudice A, Cristalli C, Manara M, Mancarella C, Parra A, et al.
Cell Oncol (Dordr)
. 2022 Nov;
45(6):1253.
PMID: 36352194
No abstract available.
6.
Martinelli M, Mancarella C, Scapoli L, Palmieri A, De Sanctis P, Ferrari C, et al.
Front Oncol
. 2022 Nov;
12:968884.
PMID: 36338681
Ewing sarcoma (EWS), the second most common malignant bone tumor in children and adolescents, occurs abruptly without clear evidence of tumor history or progression. Previous association studies have identified some...
7.
Pellegrini E, Desando G, Petretta M, Cellamare A, Cristalli C, Pasello M, et al.
Polymers (Basel)
. 2022 Oct;
14(19).
PMID: 36236019
The biological and therapeutic limits of traditional 2D culture models, which only partially mimic the complexity of cancer, have recently emerged. In this study, we used a 3D bioprinting platform...
8.
Pasello M, Giudice A, Cristalli C, Manara M, Mancarella C, Parra A, et al.
Cell Oncol (Dordr)
. 2022 Sep;
45(6):1237-1251.
PMID: 36149602
Purpose: The relevance of the subfamily A members of ATP-binding cassette (ABCA) transporters as biomarkers of risk and response is emerging in different tumors, but their mechanisms of action have...
9.
Palmerini E, Pazzaglia L, Cevolani L, Pratelli L, Pierini M, Quattrini I, et al.
Cancers (Basel)
. 2022 Jun;
14(12).
PMID: 35740530
Background: Giant cell tumors of bone (GCTB) are osteolytic tumors. Denosumab, a RANK-L inhibitor, is approved for GCTB. Data on serum bone turnover marker (sBTM) changes are lacking. We present...
10.
De Feo A, Pazzaglia L, Ciuffarin L, Mangiagli F, Pasello M, Simonetti E, et al.
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406534
Ewing's sarcoma (EWS), an aggressive pediatric bone and soft-tissue sarcoma, has a very stable genome with very few genetic alterations. Unlike in most cancers, the progression of EWS appears to...